Search research articles
Contact Us
Filters
Showing results (51-60 of 79) with videos related to
Page
of 8
Sort By:
The Journal of Investigative Dermatology
|
February 16, 1999
IgM anti-ganglioside antibodies induced by melanoma cell vaccine correlate with survival of melanoma patients
T Takahashi, T D Johnson, Y Nishinaka, et al.
Cancer Research
|
April 1, 1992
Production and characterization of a murine/human chimeric anti-idiotype antibody that mimics ganglioside
A Hastings, S L Morrison, S Kanda, et al.
Molecular Immunology
|
June 1, 1995
Cytotoxic T cell recognition of a human melanoma derived peptide with a carboxyl-terminal alanine-proline sequence
N Morioka, Y Kikumoto, D S Hoon, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 1, 1982
Identification of a human neuroectodermal tumor antigen (OFA-I-2) as ganglioside GD2
L D Cahan, R F Irie, R Singh, et al.
Cancer Research
|
April 15, 1991
Modulation of human melanoma cells by interleukin-4 and in combination with gamma-interferon or alpha-tumor necrosis factor
D S Hoon, M Banez, E Okun, et al.
International Archives of Allergy and Applied Immunology
|
January 1, 1990
Hanganutziu-Deicher antigen as a possible target for immunotherapy of melanoma
H Nakarai, P J Chandler, K Kano, et al.
Journal of the National Cancer Institute
|
November 21, 1990
Anti-idiotype monoclonal antibody carrying the internal image of ganglioside GM3
S Yamamoto, T Yamamoto, R E Saxton, et al.
The Journal of Urology
|
December 1, 1993
Aberrant expression of gangliosides in human renal cell carcinomas
D S Hoon, E Okun, H Neuwirth, et al.
Journal of the National Cancer Institute
|
September 1, 1984
Human monoclonal antibody against ganglioside GD2: use in development of enzyme-linked immunosorbent assay for the monitoring of anti-GD2 in cancer patients
T Tai, L D Cahan, J C Paulson, et al.
International Journal of Cancer
|
March 15, 1978
Establishment of paired tumor cells and autologous virus-transformed cell lines to define humoral immune responses in melanoma and sarcoma patients
R E Saxton, R F Irie, S Ferrone, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 79) with videos related to
Sort By:
Page
of 8
The Journal of Investigative Dermatology
|
February 16, 1999
IgM anti-ganglioside antibodies induced by melanoma cell vaccine correlate with survival of melanoma patients
T Takahashi, T D Johnson, Y Nishinaka, et al.
Cancer Research
|
April 1, 1992
Production and characterization of a murine/human chimeric anti-idiotype antibody that mimics ganglioside
A Hastings, S L Morrison, S Kanda, et al.
Molecular Immunology
|
June 1, 1995
Cytotoxic T cell recognition of a human melanoma derived peptide with a carboxyl-terminal alanine-proline sequence
N Morioka, Y Kikumoto, D S Hoon, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 1, 1982
Identification of a human neuroectodermal tumor antigen (OFA-I-2) as ganglioside GD2
L D Cahan, R F Irie, R Singh, et al.
Cancer Research
|
April 15, 1991
Modulation of human melanoma cells by interleukin-4 and in combination with gamma-interferon or alpha-tumor necrosis factor
D S Hoon, M Banez, E Okun, et al.
International Archives of Allergy and Applied Immunology
|
January 1, 1990
Hanganutziu-Deicher antigen as a possible target for immunotherapy of melanoma
H Nakarai, P J Chandler, K Kano, et al.
Journal of the National Cancer Institute
|
November 21, 1990
Anti-idiotype monoclonal antibody carrying the internal image of ganglioside GM3
S Yamamoto, T Yamamoto, R E Saxton, et al.
The Journal of Urology
|
December 1, 1993
Aberrant expression of gangliosides in human renal cell carcinomas
D S Hoon, E Okun, H Neuwirth, et al.
Journal of the National Cancer Institute
|
September 1, 1984
Human monoclonal antibody against ganglioside GD2: use in development of enzyme-linked immunosorbent assay for the monitoring of anti-GD2 in cancer patients
T Tai, L D Cahan, J C Paulson, et al.
International Journal of Cancer
|
March 15, 1978
Establishment of paired tumor cells and autologous virus-transformed cell lines to define humoral immune responses in melanoma and sarcoma patients
R E Saxton, R F Irie, S Ferrone, et al.
Page
of 8